PTC Therapeutics, Inc. (PTCT)
NASDAQ · Manufacturing · Pharmaceutical preparations
PTCT price, last 12 months
Key stats
- Previous close
- $62.28
- Open
- $62.65
- Day range
- $61.66 – $63.44
- 52-week range
- $57.74 – $90.87
- Volume
- 958.2K
- Avg volume (20 days)
- 1.2M
- Market cap
- $5.2B
Performance
Technicals and fundamentals
About PTC Therapeutics, Inc.
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $5.2B